M

Medifron DBT Co Ltd
KOSDAQ:065650

Watchlist Manager
Medifron DBT Co Ltd
KOSDAQ:065650
Watchlist
Price: 2 165 KRW -2.91% Market Closed
Market Cap: 28.9B KRW

Intrinsic Value

The intrinsic value of one Medifron DBT Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 2 165 KRW, Medifron DBT Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Medifron DBT Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Medifron DBT Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Medifron DBT Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Medifron DBT Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Medifron DBT Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Medifron DBT Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Medifron DBT Co Ltd.

Explain Valuation
Compare Medifron DBT Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Medifron DBT Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medifron DBT Co Ltd

Current Assets 29.6B
Cash & Short-Term Investments 8.7B
Receivables 15B
Other Current Assets 5.9B
Non-Current Assets 39.6B
Long-Term Investments 18.6B
PP&E 7.3B
Intangibles 11.6B
Other Non-Current Assets 2.1B
Current Liabilities 39.1B
Accounts Payable 2.8B
Accrued Liabilities 1.3B
Short-Term Debt 7.1B
Other Current Liabilities 27.8B
Non-Current Liabilities 6.7B
Long-Term Debt 5B
Other Non-Current Liabilities 1.8B
Efficiency

Free Cash Flow Analysis
Medifron DBT Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medifron DBT Co Ltd

Revenue
64.9B KRW
Cost of Revenue
-57.9B KRW
Gross Profit
7B KRW
Operating Expenses
-14B KRW
Operating Income
-7B KRW
Other Expenses
-44.2B KRW
Net Income
-51.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Medifron DBT Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Operating Margin is Increasing
Sustainable 3Y Average Gross Margin
Healthy Gross Margin
hidden
Profitability
Score

Medifron DBT Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Medifron DBT Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
hidden
Solvency
Score

Medifron DBT Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Medifron DBT Co Ltd

There are no price targets for Medifron DBT Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Medifron DBT Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Medifron DBT Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Medifron DBT Co Ltd stock?

The intrinsic value of one Medifron DBT Co Ltd stock under the Base Case scenario is hidden KRW.

Is Medifron DBT Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2 165 KRW, Medifron DBT Co Ltd is hidden .

Back to Top